AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.312
-0.043 (-12.18%)
Jun 26, 2026, 4:00 PM EDT - Market closed
AIM ImmunoTech Stock Forecast
AIM's stock price has decreased by -96.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AIM ImmunoTech stock have an average target of 5.25, with a low estimate of 1.50 and a high estimate of 9.00. The average target predicts an increase of 1,582.15% from the current stock price of 0.31.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AIM ImmunoTech stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $1.5 | Buy | Reiterates | $1.5 | +380.62% | Jun 2, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +2,783.69% | May 31, 2026 |
Financial Forecast
Revenue This Year
61.00K
from 88.00K
Decreased by -30.68%
Revenue Next Year
50.00K
from 61.00K
Decreased by -18.03%
EPS This Year
-0.63
from -8.62
EPS Next Year
-0.52
from -0.63
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100,000 | 100,000 | |
| Avg | 61,000 | 50,000 | |
| Low | 22,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.6% | 63.9% | |
| Avg | -30.7% | -18.0% | |
| Low | -75.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.63 | -0.52 | |
| Avg | -0.63 | -0.52 | |
| Low | -0.63 | -0.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.